We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Expanding medicine reclassification could improve access to treatments, empower self-care, and reduce pressure on NHS services.
As with any medicine, the MHRA will keep the safety and effectiveness of deuruxolitinib under close review.
New analysis shows Clinical Practice Research Datalink has supported groundbreaking medical research across 29 countries with close to 3,800 published studies
The MHRA has advised pharmacy and healthcare professionals to return all remaining stock to their suppliers
UK Space Agency, MHRA, RIO and CAA set out support for in-orbit manufacturing of pharmaceuticals
Patients could benefit from more effective, higher quality and longer lasting medicines as the UK sets out a clearer route to bring drugs manufactured in space safely to market.
A man who unlawfully supplied Class B and Class C controlled drugs and a range of unauthorised medicines has been sentenced at Stoke-on-Trent Crown Court following an investigation by the MHRA’s Criminal Enforcement Unit.
The MHRA invited the next generation of doctors to explore how genetics could improve prescribing and patient safety in the UK.
Officers from the MHRA's Criminal Enforcement Unit (CEU) have raided two separate premises as part of an ongoing investigation into an organised criminal network involved in the manufacture and sale of unlicensed weight …
Fake medicines are illegally produced products that may contain incorrect ingredients, no active ingredients, or harmful substances.
As with any medicine, the MHRA will keep the safety and effectiveness of imlunestrant tosylate under close review.
This response agrees with recommendations from the Advisory Council on the Misuse of Drugs (ACMD) in 3 reports about the control and scheduling of 5 medicines.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister for Policing and Crime Prevention, about the consideration of ganaxolone.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister for Policing and Crime Prevention, about zuranolone.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister for Policing and Crime Prevention, about 3 growth hormone agonists.
As with any medicine, the MHRA will keep the safety and effectiveness of brensocatib under close review.
MHRA has raised new concerns around the PATHWAYS trial looking into the prescription of puberty blockers among young people with gender incongruence.
Innovators across the UK are being offered £20 million in grants for technology designed to reduce harm and death from drug and alcohol addiction.
Zanidatamab is used when the cancer cannot be removed by surgery and has spread to nearby tissues or other parts of the body.
Patients benefit from earlier access to technologies that could improve or save lives, as the MHRA approved 17 per cent more clinical investigations in 2025 compared with 2024, and launches measures to support innovation and…
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).